Quarterly report pursuant to Section 13 or 15(d)

Investment in account receivable (Details Narrative)

v3.22.2.2
Investment in account receivable (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Feb. 16, 2022
Apr. 10, 2015
Sep. 30, 2022
Mar. 31, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Warrants price per share     $ 2.14     $ 2.14   $ 2.11
Warrants redemption price     $ 0.10     $ 0.10    
Impairment of investments               $ 116,430
Amortization of debt discount     $ 12,916   $ 15,228 $ 38,754 $ 45,684  
Exchange Agreement [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Account receivable with annual installment payments   $ 117,000            
Annual installment receivable, term   11 years            
Shares issued, value   $ 1,287,000            
Shares issued, shares   757,059            
Investment in account receivable discount percent               17.87%
Annual payments $ 100,000              
Annual payment term 4 years              
Debt instrument, periodic payment $ 100              
Loss on investment       $ 41,930        
Exchange Agreement [Member] | Series D Warrants [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Warrants issued   757,059            
Warrants price per share   $ 1.60            
Warrants redemption price   $ 0.10